[Therapetic measures in myasthenia gravis].
D000293:Adolescent; D000328:Adult; D000549:Ambenonium Chloride / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000145:classification / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D009388:Neostigmine / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use*
D009388:Neostigmine; D000549:Ambenonium Chloride; D011729:Pyridostigmine Bromide
Prsidi terapeutici nella miastenia grave.